BioLife Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. 

CEO
Roderick de Greef
CEORoderick de Greef
Employees
155
Employees155
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1987
Founded1987
Employees
155
Employees155

BLFS Key Statistics

Market cap
970.83M
Market cap970.83M
Price-Earnings ratio
-66.06
Price-Earnings ratio-66.06
Dividend yield
Dividend yield
Average volume
609.70K
Average volume609.70K
High today
$20.70
High today$20.70
Low today
$19.95
Low today$19.95
Open price
$20.30
Open price$20.30
Volume
638.13K
Volume638.13K
52 Week high
$29.62
52 Week high$29.62
52 Week low
$19.10
52 Week low$19.10

Stock Snapshot

The current BioLife Solutions(BLFS) stock price is $20.12, with a market capitalization of 970.83M. The stock trades at a price-to-earnings (P/E) ratio of -66.06.

On 2026-03-05, BioLife Solutions(BLFS) stock traded between a low of $19.95 and a high of $20.70. Shares are currently priced at $20.12, which is +0.9% above the low and -2.8% below the high.

The BioLife Solutions(BLFS)'s current trading volume is 638.13K, compared to an average daily volume of 609.7K.

In the last year, BioLife Solutions(BLFS) shares hit a 52-week high of $29.62 and a 52-week low of $19.10.

In the last year, BioLife Solutions(BLFS) shares hit a 52-week high of $29.62 and a 52-week low of $19.10.

BLFS News

TipRanks 3d
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation

An announcement from BioLife Solutions ( (BLFS) ) is now available. On March 2, 2026 BioLife Solutions issued an investor presentation outlining its current po...

Simply Wall St 4d
Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS?

In February 2026, BioLife Solutions, Inc. reported fourth-quarter 2025 sales of US$24.76 million, full-year 2025 sales of US$96.21 million, a reduced full-year...

Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS?
The Motley Fool 7d
BioLife Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Feb. 26, 2026 at 4:30 p.m. ET Call participants Chief Financial Officer — Troy Wichterman Interim Chief Executive Offi...

BioLife Q4 2025 Earnings Call Transcript

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.